| Code |
Title |
|
–
|
Top Categories
|
|
3 |
Administration
|
|
3E |
Physiological Systems and Anatomical Regions
|
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
|
3E0J |
Biliary and Pancreatic Tract
|
|
3E0J3 |
Percutaneous
|
|
3E0J30 |
Antineoplastic
|
|
3E0J304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J32 |
Anti-infective
|
|
3E0J328
|
Oxazolidinones
Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J329
|
Other Anti-infective
Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J33 |
Anti-inflammatory
|
|
3E0J33Z
|
No Qualifier
Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J36 |
Nutritional Substance
|
|
3E0J36Z
|
No Qualifier
Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J37 |
Electrolytic and Water Balance Substance
|
|
3E0J37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3B |
Anesthetic Agent
|
|
3E0J3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3G |
Other Therapeutic Substance
|
|
3E0J3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3H |
Radioactive Substance
|
|
3E0J3HZ
|
No Qualifier
Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3K |
Other Diagnostic Substance
|
|
3E0J3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3N |
Analgesics, Hypnotics, Sedatives
|
|
3E0J3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3S |
Gas
|
|
3E0J3SF
|
Other Gas
Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3T |
Destructive Agent
|
|
3E0J3TZ
|
No Qualifier
Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3U |
Pancreatic Islet Cells
|
|
3E0J3U0
|
Autologous
Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J3U1
|
Nonautologous
Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
|
|
3E0J4 |
Percutaneous Endoscopic
|
|
3E0J4G |
Other Therapeutic Substance
|
|
3E0J4GC
|
Other Substance
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach
|
|
3E0J7 |
Via Natural or Artificial Opening
|
|
3E0J70 |
Antineoplastic
|
|
3E0J704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J72 |
Anti-infective
|
|
3E0J728
|
Oxazolidinones
Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J729
|
Other Anti-infective
Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J73 |
Anti-inflammatory
|
|
3E0J73Z
|
No Qualifier
Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J76 |
Nutritional Substance
|
|
3E0J76Z
|
No Qualifier
Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J77 |
Electrolytic and Water Balance Substance
|
|
3E0J77Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7B |
Anesthetic Agent
|
|
3E0J7BZ
|
No Qualifier
Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7G |
Other Therapeutic Substance
|
|
3E0J7GC
|
Other Substance
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7H |
Radioactive Substance
|
|
3E0J7HZ
|
No Qualifier
Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7K |
Other Diagnostic Substance
|
|
3E0J7KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7N |
Analgesics, Hypnotics, Sedatives
|
|
3E0J7NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7S |
Gas
|
|
3E0J7SF
|
Other Gas
Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7T |
Destructive Agent
|
|
3E0J7TZ
|
No Qualifier
Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7U |
Pancreatic Islet Cells
|
|
3E0J7U0
|
Autologous
Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J7U1
|
Nonautologous
Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
|
|
3E0J8 |
Via Natural or Artificial Opening Endoscopic
|
|
3E0J80 |
Antineoplastic
|
|
3E0J804
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J805
|
Other Antineoplastic
Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J80M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J82 |
Anti-infective
|
|
3E0J828
|
Oxazolidinones
Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J829
|
Other Anti-infective
Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J83 |
Anti-inflammatory
|
|
3E0J83Z
|
No Qualifier
Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J86 |
Nutritional Substance
|
|
3E0J86Z
|
No Qualifier
Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J87 |
Electrolytic and Water Balance Substance
|
|
3E0J87Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8B |
Anesthetic Agent
|
|
3E0J8BZ
|
No Qualifier
Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8G |
Other Therapeutic Substance
|
|
3E0J8GC
|
Other Substance
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8H |
Radioactive Substance
|
|
3E0J8HZ
|
No Qualifier
Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8K |
Other Diagnostic Substance
|
|
3E0J8KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8N |
Analgesics, Hypnotics, Sedatives
|
|
3E0J8NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8S |
Gas
|
|
3E0J8SF
|
Other Gas
Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8T |
Destructive Agent
|
|
3E0J8TZ
|
No Qualifier
Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8U |
Pancreatic Islet Cells
|
|
3E0J8U0
|
Autologous
Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|
|
3E0J8U1
|
Nonautologous
Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
|